•
SE
SEER
Seer, Inc. Class A Common Stock
polygonLABORATORY ANALYTICAL INSTRUMENTS
--
Price Chart
Market Cap
105.75M
Volume
18.42K
52W High
$2.44
52W Low
$1.62
Open
$1.90
Prev Close
$1.88
Day Range
1.86 - 1.92
About Seer, Inc. Class A Common Stock
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
Latest News
Seer and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025
GlobeNewswire Inc.•Nov 7
Next-Gen Proteomics Market Size, Trends, Competitive Analysis – Towards Healthcare
GlobeNewswire Inc.•Oct 24
Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics (ASHG) 2025
GlobeNewswire Inc.•Oct 10
Seer (SEER) Q2 Revenue Jumps 32%
The Motley Fool•Aug 7
Seer’s Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults
GlobeNewswire Inc.•Jun 1
Seer to Feature Proteomic Advancements in Cancer and RNA Therapy Research among other Findings at US HUPO 2025
GlobeNewswire Inc.•Feb 20
Seer Proteographâ„¢ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery
GlobeNewswire Inc.•Jun 11
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study
GlobeNewswire Inc.•Jun 2